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J.10 Detection of autoantibodies against exocrine pancreas by double 
immunodiffusion testing 
W I E B K E RÖGENER, W . STÖCKER, M . O T T E , E. H O R B A C H , D O R I S KAISER, and P. C. SCRIBA 
Autoantibodies against a component of pancreatic juice (PAb) occur in 39 % of patients 
w i t h Crohn's disease (CD) , as determined by indirect immunofluorescence ( I IF ; 1). In the 
XXIs t Meeting of the Society of Immunology • 221 
present study double immunodiffusion ( D I D ) testing was used as an alternative method for the 
detection of PAb, and results were compared to those of I IF . Serum samples from 70 patients 
with C D were tested, 35 of which were PAb-positive in I IF , the other 35 were PAb-negative. 
Furthermore, 35 sera from patients wi th different diagnoses were used which were PAb-
negative in I I F . D I D was performed with 1 % agarose gels in 0.1 M Tris buffer, p H 8.0, 
containing 2.5 % polyethyleneglycol 6000. Monoclonal antibody H L - 1 to PAg was used as a 
positive control . PAg was enriched from homogenized human pancreas by size exclusion 
chromatography and ammonium sulphate precipitation. Gels were incubated for 7 days at 
4°C, dried and stained w i t h Serva blue R. O f 35 sera positive in I IF , 30 showed clear 
precipitation lines. In 2 other cases precipitation was only weak. Three IIF-positive samples 
did not react in D I D . A l l sera which were negative in I I F were negative in D I D . Reactions of 
identity were seen with most positive sera, but 5 precipitation lines crossed over, indicating 
that autoantibodies to exocrine pancreas may react wi th different epitopes or even different 
components of the crude antigen preparation used. The epitopes recognized by H L - 1 seemed 
to be different f rom those reacting w i t h PAb of serum samples. Despite long incubation times, 
D I D is a convenient, easy to handle complementary method for the detection of autoan-
tibodies against exocrine pancreas which enables the diagnosis of many cases of C D in 
laboratories where I IF testing is not established. 
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